Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

Home
Search
PMID 40019747

FDA Approves Semaglutide to Reduce Risk of Kidney Disease Progression.

JAMA2025PMID: 40019747

View on PubMed DOI: 10.1001/jama.2025.0548

Authors

Anderer, Samantha

FDA Approves Semaglutide to Reduce Risk of Kidney Disease Progression. | Pepdox